Tianjin-based vaccine producer CanSino Biologics announced its vaccine candidate, jointly developed with the Academy of Military Medical Sciences of the People’s Liberation Army, is recruiting healthy volunteers for a six-month clinical trial. Photo: Weibo
Tianjin-based vaccine producer CanSino Biologics announced its vaccine candidate, jointly developed with the Academy of Military Medical Sciences of the People’s Liberation Army, is recruiting healthy volunteers for a six-month clinical trial. Photo: Weibo

How a Chinese pharmaceutical firm has leapt to the front of the global race for a vaccine while the pandemic rages on

  • CanSino Biologics is vaulting into the global spotlight as connections on both sides of the Pacific make it one of the front-runners in the race for a coronavirus vaccine
  • In May, CanSino became the first globally to publish a full scientific study on its early human trials, an important step because it allows researchers worldwide to assess a vaccine’s potential

Tianjin-based vaccine producer CanSino Biologics announced its vaccine candidate, jointly developed with the Academy of Military Medical Sciences of the People’s Liberation Army, is recruiting healthy volunteers for a six-month clinical trial. Photo: Weibo
Tianjin-based vaccine producer CanSino Biologics announced its vaccine candidate, jointly developed with the Academy of Military Medical Sciences of the People’s Liberation Army, is recruiting healthy volunteers for a six-month clinical trial. Photo: Weibo
READ FULL ARTICLE